IVZNEUTRAL

IVZ Gross Margin Analysis

35.7%

Updated 273h ago·SEC filings & market data

Key Takeaway

Gross margin is the share of revenue left after subtracting the direct cost of delivering a product or service, and 35.7% means IVZ keeps 35.7 cents of each sales dollar before other expenses.

Sector Performance

29th percentile

IVZ

35.7%

Sector Median

46.6%

Sector Avg

47.6%

Prior Period

36.1%(Aug 2026)

↓ Declining
📊

Deep Analysis

Gross margin is the share of revenue left after subtracting the direct cost of delivering a product or service, and 35.7% means IVZ keeps 35.7 cents of each sales dollar before other expenses.

This trails its sector, as the sector median is 45.4%, and IVZ sits at the 32nd percentile among peers. For the trend, the year-over-year change is not available, but quarter-over-quarter the metric fell 1.1 percentage points from 36.1% to 35.7%. This combination — a level below the peer midpoint plus a recent quarterly decline — points to cost or pricing pressure that raises risk for margin stability. The

Frequently Asked Questions

What does the Gross Margin tell investors about IVZ?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

Who are IVZ's closest peers by Gross Margin?

The closest peers by Gross Margin include: LVS (46.9%), ORLY (51.4%), MPWR (55.2%), NEM (56.0%), REI (56.0%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master IVZ's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full IVZ research report

Free account — no credit card

IVZ

35.7%

Sector Median

46.6%

Sector Avg

47.6%

How IVZ's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.